 Submission of EXXUA gepirone HCl, a novel targeted single serotonin receptor agonist for treatment of Major Depressive Disorder receives PDUFA action date of June 23, 2023. HOUSTON, Jan. 24, 2023 PRNewswire Fabre-Kramer Pharmaceuticals, a leading developer of novel small molecule medications to address unmet needs in the treatment of psychiatric and neurological disorders, announced ...... 